Risk of post-operative complications associated with anti-TNF therapy in inflammatory bowel disease

Tauseef Ali, Laura Yun, David T. Rubin

Research output: Contribution to journalReview article

27 Citations (Scopus)

Abstract

There have been increasing concerns regarding the safety of perioperative anti-tumour necrosis factor (anti-TNF) α agents. We performed a literature review to evaluate the post-operative complications associated with perioperative anti-TNF use in patients with inflammatory bowel disease. A comprehensive review was performed with a literature search utilizing Pub Med, Cochrane, OVID and EMBASE databases according to published guidelines. To date, there are only data for infliximab. There are three published studies which have assessed post-operative complications with perioperative infliximab use in patients with Crohn's disease (CD), four studies in ulcerative colitis (UC) patients, and one study on both CD and UC patients. Two out of the three studies in CD patients showed no increased post-operative complications associated with perioperative infliximab. Two out of four studies in UC patients also did not show an increase in post-operative complications, and the combined study with CD and UC patients did not show an increased risk as well. Study results could not be combined secondary to significant differences in study designs, patient population and definition of their endpoints. There appears to be a risk of post-operative complications associated with TNF therapy in some patients. Based on these data, careful patient selection and prospective data collection should be performed.

Original languageEnglish (US)
Pages (from-to)197-204
Number of pages8
JournalWorld Journal of Gastroenterology
Volume18
Issue number3
DOIs
StatePublished - Jan 21 2012

Fingerprint

Inflammatory Bowel Diseases
Tumor Necrosis Factor-alpha
Ulcerative Colitis
Crohn Disease
Therapeutics
Patient Selection
Databases
Guidelines
Safety
Population

Keywords

  • Colectomy
  • Crohn's disease
  • Post-operative complications
  • Ulcerative colitis

ASJC Scopus subject areas

  • Gastroenterology

Cite this

@article{46769621f73b4dd2a3626ea9d5389ed0,
title = "Risk of post-operative complications associated with anti-TNF therapy in inflammatory bowel disease",
abstract = "There have been increasing concerns regarding the safety of perioperative anti-tumour necrosis factor (anti-TNF) α agents. We performed a literature review to evaluate the post-operative complications associated with perioperative anti-TNF use in patients with inflammatory bowel disease. A comprehensive review was performed with a literature search utilizing Pub Med, Cochrane, OVID and EMBASE databases according to published guidelines. To date, there are only data for infliximab. There are three published studies which have assessed post-operative complications with perioperative infliximab use in patients with Crohn's disease (CD), four studies in ulcerative colitis (UC) patients, and one study on both CD and UC patients. Two out of the three studies in CD patients showed no increased post-operative complications associated with perioperative infliximab. Two out of four studies in UC patients also did not show an increase in post-operative complications, and the combined study with CD and UC patients did not show an increased risk as well. Study results could not be combined secondary to significant differences in study designs, patient population and definition of their endpoints. There appears to be a risk of post-operative complications associated with TNF therapy in some patients. Based on these data, careful patient selection and prospective data collection should be performed.",
keywords = "Colectomy, Crohn's disease, Post-operative complications, Ulcerative colitis",
author = "Tauseef Ali and Laura Yun and Rubin, {David T.}",
year = "2012",
month = "1",
day = "21",
doi = "10.3748/wjg.v18.i3.197",
language = "English (US)",
volume = "18",
pages = "197--204",
journal = "World Journal of Gastroenterology",
issn = "1007-9327",
publisher = "WJG Press",
number = "3",

}

Risk of post-operative complications associated with anti-TNF therapy in inflammatory bowel disease. / Ali, Tauseef; Yun, Laura; Rubin, David T.

In: World Journal of Gastroenterology, Vol. 18, No. 3, 21.01.2012, p. 197-204.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Risk of post-operative complications associated with anti-TNF therapy in inflammatory bowel disease

AU - Ali, Tauseef

AU - Yun, Laura

AU - Rubin, David T.

PY - 2012/1/21

Y1 - 2012/1/21

N2 - There have been increasing concerns regarding the safety of perioperative anti-tumour necrosis factor (anti-TNF) α agents. We performed a literature review to evaluate the post-operative complications associated with perioperative anti-TNF use in patients with inflammatory bowel disease. A comprehensive review was performed with a literature search utilizing Pub Med, Cochrane, OVID and EMBASE databases according to published guidelines. To date, there are only data for infliximab. There are three published studies which have assessed post-operative complications with perioperative infliximab use in patients with Crohn's disease (CD), four studies in ulcerative colitis (UC) patients, and one study on both CD and UC patients. Two out of the three studies in CD patients showed no increased post-operative complications associated with perioperative infliximab. Two out of four studies in UC patients also did not show an increase in post-operative complications, and the combined study with CD and UC patients did not show an increased risk as well. Study results could not be combined secondary to significant differences in study designs, patient population and definition of their endpoints. There appears to be a risk of post-operative complications associated with TNF therapy in some patients. Based on these data, careful patient selection and prospective data collection should be performed.

AB - There have been increasing concerns regarding the safety of perioperative anti-tumour necrosis factor (anti-TNF) α agents. We performed a literature review to evaluate the post-operative complications associated with perioperative anti-TNF use in patients with inflammatory bowel disease. A comprehensive review was performed with a literature search utilizing Pub Med, Cochrane, OVID and EMBASE databases according to published guidelines. To date, there are only data for infliximab. There are three published studies which have assessed post-operative complications with perioperative infliximab use in patients with Crohn's disease (CD), four studies in ulcerative colitis (UC) patients, and one study on both CD and UC patients. Two out of the three studies in CD patients showed no increased post-operative complications associated with perioperative infliximab. Two out of four studies in UC patients also did not show an increase in post-operative complications, and the combined study with CD and UC patients did not show an increased risk as well. Study results could not be combined secondary to significant differences in study designs, patient population and definition of their endpoints. There appears to be a risk of post-operative complications associated with TNF therapy in some patients. Based on these data, careful patient selection and prospective data collection should be performed.

KW - Colectomy

KW - Crohn's disease

KW - Post-operative complications

KW - Ulcerative colitis

UR - http://www.scopus.com/inward/record.url?scp=84856988917&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84856988917&partnerID=8YFLogxK

U2 - 10.3748/wjg.v18.i3.197

DO - 10.3748/wjg.v18.i3.197

M3 - Review article

VL - 18

SP - 197

EP - 204

JO - World Journal of Gastroenterology

JF - World Journal of Gastroenterology

SN - 1007-9327

IS - 3

ER -